- Available:In stock1424
- Availability date:2020-07-30
- Dosage form:Drops (Bottle)
- In stock:1424 Items
herbal preparation for the treatment of premenopausal and menopausal disorders.
The extract of tsimitsifugi positively affects the neurovegetative system and reduces the level of psychoemotional disturbances in menopause. The use of the drug contributes to the weakening or complete disappearance of the symptoms of the disease in the premenopausal and menopausal period, including such as hot flashes and excessive sweating.
Pharmacokinetics No data available.
Neurovegetative disorders during premenopause, menopause, postmenopause (hot flashes, increased sweating, sleep disorders, increased irritability, mood swings, apathy).
Klimadynon is administered orally by 30 drops or 1 tablet 2 times a day, preferably at the same time (morning and evening). drops are taken undiluted or with sugar, they must be shaken before use. tablets are swallowed without chewing. therapeutic effect is manifested approximately 2 weeks after the start of the drug. the course of therapy is determined individually (3-6 months). the drug should not be taken for more than 6 months without consulting a doctor.
Klimadynon Uno. If the doctor has not prescribed another, for women during menopause, the drug should be taken 1 tablet 1 time per day, preferably at the same time (in the evening).
The tablets should be swallowed without chewing, drinking plenty of fluids.
Do not take a double dose if the patient has missed 1 dose. The duration of the course of treatment is determined by the doctor individually. The course can be from 3 to 6 months.
If symptoms persist during treatment, consult a doctor. Do not use the drug for more than 6 months without consulting a doctor.
Hypersensitivity to the active substance or other components of the drug. estrogen-dependent tumors.
When using preparations containing tsimitsifugu, cases of gastrointestinal disorders (including dyspeptic disorders, diarrhea, nausea, vomiting), allergic reactions (including rash, itching, urticaria), facial swelling and peripheral edema were noted. with the use of preparations containing tsimitsifugu, hepatotoxic reactions (including hepatitis, jaundice, violations of laboratory parameters of liver function) are associated. there were reports of a sensation of tension in the mammary glands and menstrual bleeding.
In case of any adverse reactions should stop using the drug and consult a doctor.
Patients with impaired liver function should take the drug with caution. if there are signs of liver damage (increased fatigue, loss of appetite, yellowing of the skin and eyes or severe pain in the upper abdomen with nausea and vomiting, or dark urine), you should stop using the drug climadinone and immediately consult a doctor.
In case of violation or resumption of menstruation, as well as in the case of prolonged menstruation or other complaints that occur during treatment, it is necessary to consult a doctor to review the treatment regimen.
Women of reproductive age need to use effective contraceptives.
Klimadynon should not be used without consulting a doctor if the patient is already taking female sex hormones (estrogens).
If the severity of symptoms increases while taking Klimadynon, consult a doctor.
The drug contains lactose, therefore, patients with rare hereditary forms of galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome should not use the drug.
Drops contain 38% ethanol, and a single dose contains a small amount of XE.Tablets contain lactose, so patients with rare hereditary forms of galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome should not use the drug. 1 tablet contains an average of 0.01 XE.
During pregnancy and breastfeeding. The safety of tsimitsifugi during pregnancy and lactation has not been established, therefore, the drug should not be used during this period.
Children. The drug is not used in children.
The ability to influence the reaction rate when driving vehicles or working with other mechanisms. In recommended doses, the drug does not affect the ability to drive vehicles or work with other mechanisms, but it should be remembered that Klimadynon in the form of drops contains alcohol.
When combined with estrogens, climadinone can enhance their effect (see special instructions).
When taking doses exceeding the recommended, you should inform your doctor about this to take the necessary measures. in case of an overdose, symptomatic therapy is necessary.
Klimadynon - in the original packaging in a dark place at a temperature of no higher than 25 ° C; an open bottle should be used within 6 months.
Klimadynon Uno - at room temperature in the original packaging in order to protect from the effects of light, at a temperature not exceeding 30 ° C.